25
Participants
Start Date
July 31, 2020
Primary Completion Date
April 22, 2024
Study Completion Date
December 30, 2024
PD-1 Antibody
PD-1 antibody 240mg,I.V,D1,repeat every 3 weeks, Four cycles in the neoadjuvant treatment, and four cycles in the adjuvant treatment,
Oxaliplatin
Oxiliplatin 130mg/m\^2 (100mg/m\^2 during radiotherapy),I.V,D1,repeat every 3 weeks, Four cycles in the neoadjuvant treatment in Capeox regimen, and two cycles in the adjuvant treatment in Capeox regimen
Capecitabine
Capecitabine 1000mg/m\^2,Bid,P.O,D1-D14,repeat every 3 weeks, Four cycles in the neoadjuvant treatment in Capeox regimen, and two cycles in the adjuvant treatment in Capeox regimen, and two cycles in adjuvant treatment in Capecitabine regimen
External beam radiotherapy
Neoadjuvant radiotherapy, 50Gy/25Fractions to the GTV, 45Gy/25Fractions to the CTV
Total mesorectal excision
Total mesorectal excision
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER